| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| G7J1H1 | Disease resistance protein (CC-NBS-LRR class) family protein; | MTR_3g055830; | XP_003600233.1; | 915 | barrel-medic |
| Q2HRN5 | Putative uncharacterized protein; | NULL | NULL | 49 | barrel-medic |
| G7J7M8 | Uncharacterized protein; | MTR_3g104390; | NULL | 125 | barrel-medic |
| G7KVX2 | Uncharacterized protein; | MTR_7g050780; | XP_003622681.1; | 137 | barrel-medic |
| A2Q245 | CENP-B homolog protein 2 ; CENP-B homolog; CENP-B box; C-terminal dimerization d, related; | NULL | NULL | 120 | barrel-medic |
| A2Q4K9 | Putative uncharacterized protein; | NULL | NULL | 52 | barrel-medic |
| G7L8Q0 | Serine/Threonine kinase family protein; | MTR_8g073250; | NULL | 442 | barrel-medic |
| G7KPB8 | Complex 1 LYR-like protein; | MTR_6g068850; | XP_003619775.1; | 110 | barrel-medic |
| G7IIE5 | Transmembrane protein, putative; | MTR_2g038740; | XP_003595137.1; | 678 | barrel-medic |
| G7L8X4 | Uncharacterized protein; | MTR_8g103530; | XP_003630798.1; | 203 | barrel-medic |
| G7II66 | Uncharacterized protein; | MTR_2g103820; | XP_003597902.1; | 74 | barrel-medic |
| G7IVT7 | Uncharacterized protein; | MTR_3g013450; | XP_003598420.1; | 140 | barrel-medic |
| A4PSE7 | H+-transporting two-sector ATPase, alpha/beta subunit, central region, related; | NULL | NULL | 108 | barrel-medic |
| G7IWF8 | Zinc finger, C3HC4 type (RING finger) protein; | MTR_3g025380; | XP_003598958.1; | 141 | barrel-medic |
| A2Q4L1 | Putative uncharacterized protein; | NULL | NULL | 43 | barrel-medic |
| G7J275 | Uncharacterized protein; | MTR_3g061730; | XP_003600487.1; | 79 | barrel-medic |
| G7J863 | Metal-dependent protein hydrolase; | MTR_3g092050; | XP_003602310.1; | 345 | barrel-medic |
| G7J7X1 | Zinc finger CCCH domain protein; | MTR_3g064270; | NULL | 789 | barrel-medic |
| G7LEU0 | Cytochrome P450 family 90 protein; | MTR_8g077810; | NULL | 508 | barrel-medic |
| G7J922 | Nascent proteinassociated complex alpha chain; | MTR_3g092980; | XP_003602403.1; | 218 | barrel-medic |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |